
Compound Ipratropium bromide solution for inhalation
Generic Name:
Compound Ipratropium bromide solution for inhalation
Indications:
This product is indicated for patients requiring the combined use of multiple bronchodilators, for the treatment of reversible bronchospasm associated with obstructive airway diseases.
Dosage Forms and Strengths
Each 2.5 ml single dose unit contains 500 micrograms ipratropium bromide (as 520 micrograms ipratropium bromide monohydrate) and 3 mg salbutamol sulfate (corresponds to 2.5mg salbutamol base).
- Description
-
Generic Name:Compound Ipratropium bromide solution for inhalation
Indications:This product is indicated for patients requiring the combined use of multiple bronchodilators, for the treatment of reversible bronchospasm associated with obstructive airway diseases.
Dosage Forms and Strengths:Each 2.5 ml single dose unit contains 500 micrograms ipratropium bromide (as 520 micrograms ipratropium bromide monohydrate) and 3 mg salbutamol sulfate (corresponds to 2.5mg salbutamol base).
Dosage and Administration:The usual dose is the contents of 1 single dose unit, three or four times a day for: Adults (including the elderly) and children over 12 years. The treatment with the nebuliser solution should always be started with the lowest recommended dose. In very severe cases two unit dose vials may be required for symptom relief. Administration should be stopped when sufficient symptom relief is achieved.